Beijing Beilu Pharmaceutical Financial Flexibility Index
Beijing Beilu Pharmaceutical financial flexibility index. Beijing Beilu Pharmaceutical (300016) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of CN¥132.62 Million (operating CF CN¥74.66 Million minus capex CN¥57.96 Million) represents 0% of total liabilities (CN¥852.80 Million). Explore Beijing Beilu Pharmaceutical capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Beijing Beilu Pharmaceutical (2006–2024)
Financial flexibility index of Beijing Beilu Pharmaceutical from 2006 to 2024. Historical Financial Flexibility Index trend for Beijing Beilu Pharmaceutical across 19 annual periods. Check how aggressively does Beijing Beilu Pharmaceutical reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Beijing Beilu Pharmaceutical Financial Flexibility Index by Year (2006–2024)
Beijing Beilu Pharmaceutical financial flexibility index by year from 2006 to 2024. Year-by-year free cash flow to debt coverage for Beijing Beilu Pharmaceutical. For the full cash flow conversion analysis, see 300016 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | CN¥264.41 Million | CN¥163.02 Million | CN¥1.15 Billion | ▲ +17.2% |
| 2023 | 0.20x | CN¥203.07 Million | CN¥58.46 Million | CN¥1.03 Billion | ▼ -23.9% |
| 2022 | 0.26x | CN¥230.60 Million | CN¥127.81 Million | CN¥892.27 Million | ▼ -17.6% |
| 2021 | 0.31x | CN¥256.48 Million | CN¥108.73 Million | CN¥818.22 Million | ▼ -14.0% |
| 2020 | 0.36x | CN¥348.10 Million | CN¥176.00 Million | CN¥955.50 Million | ▼ -67.1% |
| 2019 | 1.11x | CN¥191.80 Million | CN¥156.81 Million | CN¥173.31 Million | ▼ -60.1% |
| 2018 | 2.77x | CN¥229.81 Million | CN¥175.75 Million | CN¥82.93 Million | ▼ -0.7% |
| 2017 | 2.79x | CN¥199.92 Million | CN¥144.92 Million | CN¥71.65 Million | ▲ +26.1% |
| 2016 | 2.21x | CN¥120.37 Million | CN¥76.17 Million | CN¥54.40 Million | ▲ +73.1% |
| 2015 | 1.28x | CN¥150.09 Million | CN¥80.85 Million | CN¥117.39 Million | ▲ +261.6% |
| 2014 | 0.35x | CN¥85.09 Million | CN¥42.11 Million | CN¥240.67 Million | ▼ -71.9% |
| 2013 | 1.26x | CN¥76.85 Million | CN¥41.37 Million | CN¥61.16 Million | ▼ -13.2% |
| 2012 | 1.45x | CN¥86.32 Million | CN¥22.86 Million | CN¥59.64 Million | ▼ -38.1% |
| 2011 | 2.34x | CN¥77.60 Million | CN¥45.73 Million | CN¥33.19 Million | ▼ -80.4% |
| 2010 | 11.92x | CN¥89.29 Million | CN¥37.51 Million | CN¥7.49 Million | ▲ +232.0% |
| 2009 | 3.59x | CN¥63.23 Million | CN¥57.91 Million | CN¥17.60 Million | ▲ +2616.7% |
| 2008 | -0.14x | CN¥-3.78 Million | CN¥-4.76 Million | CN¥26.52 Million | ▼ -158.6% |
| 2007 | 0.24x | CN¥12.50 Million | CN¥12.28 Million | CN¥51.36 Million | ▼ -37.7% |
| 2006 | 0.39x | CN¥21.15 Million | CN¥19.65 Million | CN¥54.10 Million | — |